These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 19953334)

  • 21. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up.
    Denzinger S; Ganzer R; Fink A; Wieland WF; Blana A
    Scand J Urol Nephrol; 2007; 41(6):496-500. PubMed ID: 17853016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.
    Bigot P; Hétet JF; Bernhard JC; Fardoun T; Audenet F; Xylinas E; Ploussard G; Pignot G; Bessede T; Ouzaid I; Robine E; Brureau L; Merigot de Treigny O; Maurin C; Long JA; Rouffilange J; Hoarau N; Lebdai S; Rouprêt M; Bastien L; Neuzillet Y; Mongiat-Artus P; Verhoest G; Zerbib M; Ravery V; Rigaud J; Bellec L; Baumert H; Chautard D; Bensalah K; Escudier B; Paparel P; Grenier N; Rioux-Leclercq N; Azzouzi AR; Soulié M; Patard JJ
    Clin Genitourin Cancer; 2014 Feb; 12(1):e19-27. PubMed ID: 24210610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
    Rouach Y; Delongchamps N; Timsit MO; Verkarre V; Fontaine E; Peyromaure M; Mejean A
    BJU Int; 2010 Mar; 105(5):616-9. PubMed ID: 19681891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
    Roos FC; Pahernik S; Brenner W; Thüroff JW
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S70-6. PubMed ID: 20094960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
    J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of elective versus imperative indications on oncologic outcomes after open nephron-sparing surgery for the treatment of sporadic renal cell carcinomas.
    Coffin G; Hupertan V; Taksin L; Vaessen C; Chartier-Kastler E; Bitker MO; Rouprêt M
    Ann Surg Oncol; 2011 Apr; 18(4):1151-7. PubMed ID: 21136181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.